TSX gains after CPI shows US inflation rose 3%
Ten Percent Owner Mark N. Tompkins of Aeluma, Inc. (ALMU) reported selling shares of common stock on October 17 and October 20, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The sales, totaling $1.29 million with prices ranging from $16.39 to $18.45, come as the $286.76 million market cap company’s stock has declined 15.31% over the past week. According to InvestingPro analysis, the stock appears slightly overvalued at current levels.
On October 17, Tompkins sold 33,344 shares in multiple transactions, with prices ranging from $16.32 to $17.31. An additional 5,913 shares were sold, with prices ranging from $17.32 to $18.31. Finally, 743 shares were sold, with prices ranging from $18.34 to $18.55. On October 20, Tompkins sold 37,500 shares in multiple transactions, with prices ranging from $16.00 to $17.00. Despite these sales, the company maintains strong liquidity with a current ratio of 24.59, and has delivered impressive returns of 474.87% over the past year. For deeper insights into insider trading patterns and 12+ additional key metrics, check out the comprehensive Pro Research Report available on InvestingPro.
Following these transactions, Tompkins directly owns 2,319,988 shares of Aeluma , Inc.
In other recent news, Aeluma, Inc. has successfully closed a public offering, raising approximately $25.4 million in gross proceeds. This offering consisted of 1,955,000 shares priced at $13.00 per share, including additional shares issued due to underwriters exercising their options. The capital raise brings Aeluma’s total cash position to around $38 million, providing the company with the flexibility to invest in manufacturing partnerships and other operational needs. Benchmark has reiterated its Buy rating for Aeluma, setting a price target of $25.00, reflecting confidence in the company’s momentum.
Additionally, Aeluma had previously announced its plans for this public offering, which was priced at $13 per share, expecting to generate $22.1 million before expenses. The company also granted underwriters a 30-day option to purchase additional shares. In a separate development, Aeluma’s director, Steven DenBaars, ended a planned stock sale arrangement without selling any shares, as disclosed in a recent SEC filing. These developments highlight Aeluma’s recent activities in capital raising and stock management.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.